Epidiolex (Cannabidiol) for EpilepsySeptember 28, 2018
Epidiolex is an oral liquid formulation of a highly purified extract of cannabidiol (CBD). CBD is a non-psychoactive component of Cannabis sativa (marijuana). It is approved by the Food and Drug Administration for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome in patients 2 years of age and older.
If you have a Hayes login, click here to view the full report on the Knowledge Center.